May 01, 2026

When the Answer Isn’t Clear: The Power of Comprehensive Data in Clinical Decision-Making

Exploring a complex case of progressive keratoconus reveals critical decision-making in clinical practice.

Optometric Management

May 01, 2026

Prior Authorization Strategies to Prevent Surgical Payment Delays

CMS policy changes and Medicare Advantage growth are expanding authorization requirements for ophthalmic surgery in the ASC setting.

Ophthalmology Management

May 01, 2026

Co-Management Strategies in GA Care: Recognizing Geographic Atrophy Earlier

Explore how recent advancements are reshaping geographic atrophy care, emphasizing the critical roles of optometrists and ophthalmologists in early detection and intervention.

Optometric Management

May 01, 2026

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

The Ophthalmologist

May 01, 2026

Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

The Ophthalmologist

May 01, 2026

Glaucoma Surgery During Pregnancy

Navigating glaucoma treatment during pregnancy poses unique challenges and requires tailored surgical considerations, as shared by Dr. Sunita Radhakrishnan at the AGS 2026 meeting.

Glaucoma Physician

May 01, 2026

Via360 Expands Canal-Based MIGS Options

Introducing the Via360 surgical system, a breakthrough in glaucoma surgery that combines precise canaloplasty and trabeculotomy for optimizing IOP management, sourced from Philip S. Garza, MD.

Glaucoma Physician

May 01, 2026

Clinical Trial Update May/June 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

April 30, 2026

Belzutifan/Lenvatinib Outperforms Cabozantinib After Checkpoint Inhibitors in Advanced Renal Cell Carcinoma

At the first and second interim analyses of the phase III LITESPARK-011 trial, treatment with the novel first-in-class hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor belzutifan plus lenvatinib im...

The ASCO Post

April 30, 2026

Acupuncture for Nocturia in Survivors of Prostate Cancer

Guest Editor’s Note: Nocturia, waking up from sleep more than once to urinate, is prevalent in survivors of prostate cancer and is associated with a diminished quality of life and a higher mortality t...

The ASCO Post